On 28 January 2022, the European Regulation on medicinal products for veterinary use has entered into force. Among other things, this implies that veterinarians have the obligation to use a new model format for veterinary prescriptions. These changes will take place in several phases.
As of 28 January 2022, Regulation 2019/6 became effective. From that moment onwards, European Member States must comply with all rules from this regulation.
Register now for the online information session on the new European veterinary medicines legislation on 15 October 2021
On 15 October 2021, the FAMHP is organising an online information session on the European Regulation 2019/6 regarding veterinary medicines. The information session is intended for people working in the Belgian pharmaceutical industry.
Following the coronavirus epidemic (COVID-19), experts at FAMHP are actively monitoring the potential impact on the availability of medication and medical devices in Belgium. The FAMHP is also supporting the European Medicines Agency (EMA) in developing COVID-19 vaccines.
Save the date: Symposium on the new European legislation on veterinary medicines. What will change for you?
Europe has approved new legislation on veterinary medicines and medicated animal feeds. What does this mean and what will change concretely for the industry or veterinarian? Learn everything at the FAMHP symposium on November 19.
The American Food and Drug Administration (FDA) has recognised the FAMHP as its Belgian counterpart under the mutual recognition agreement (MRA) between the European Union and the United States.
Until today, the good manufacturing practices (GMP) for medicinal products were only available in English. As of now, the GMP will be available in French and Dutch on the FAMHP website.
La Fondation Non à la contrefaçon et à la piraterie est présentée à la presse ce 16 juin. A travers cette Fondation, l’Administration générale des douanes et accises et la Chambre de commerce internationale (ICC Belgique) veulent sensibiliser le public aux risques et dommages de la contrefaçon. L’année 2011, première année de fonctionnement de cette Fondation, est notamment consacrée au thème des médicaments contrefaits. Dans ce cadre, l’AFMPS tient à soutenir ses actions et à lui apporter ses compétences et sa collaboration.